Skip to content

Clinical trials

Phase 2 Pathologic Processes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Phase: Phase 2 Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20096
20101
20111
20121
20164
20175
20182
20191
20201
20233
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status6
Recruiting5
Terminated4
Active, not recruiting3
Withdrawn1
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AusperBio Therapeutics Inc.2
InSilico Medicine Hong Kong Limited2
Ottawa Hospital Research Institute2
Pfizer2
Vertex Pharmaceuticals Incorporated2
Amphia Hospital1
Assistance Publique - Hôpitaux de Paris1
Celgene1
Cumberland Pharmaceuticals1
Emerald Health Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes33
Fibrosis8
Cardiovascular Diseases6
Neoplasms6
Respiratory Tract Diseases6
Digestive System Diseases5
Infections5
Inflammation5
Lung Diseases5
Neoplasms by Histologic Type5

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.